Choreo LLC Has $846,000 Stake in Celanese Co. (NYSE:CE)

Choreo LLC boosted its stake in shares of Celanese Co. (NYSE:CEFree Report) by 28.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,335 shares of the basic materials company’s stock after acquiring an additional 2,733 shares during the quarter. Choreo LLC’s holdings in Celanese were worth $846,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. DT Investment Partners LLC increased its holdings in Celanese by 128.8% during the 3rd quarter. DT Investment Partners LLC now owns 183 shares of the basic materials company’s stock valued at $25,000 after purchasing an additional 103 shares in the last quarter. UMB Bank n.a. grew its holdings in shares of Celanese by 103.7% during the fourth quarter. UMB Bank n.a. now owns 381 shares of the basic materials company’s stock worth $26,000 after purchasing an additional 194 shares during the last quarter. CKW Financial Group increased its stake in shares of Celanese by 52.9% in the fourth quarter. CKW Financial Group now owns 535 shares of the basic materials company’s stock valued at $37,000 after buying an additional 185 shares in the last quarter. CENTRAL TRUST Co raised its holdings in shares of Celanese by 43.2% in the fourth quarter. CENTRAL TRUST Co now owns 670 shares of the basic materials company’s stock valued at $46,000 after buying an additional 202 shares during the last quarter. Finally, Mather Group LLC. lifted its position in Celanese by 124.0% during the 3rd quarter. Mather Group LLC. now owns 401 shares of the basic materials company’s stock worth $55,000 after buying an additional 222 shares in the last quarter. 98.87% of the stock is owned by institutional investors.

Analyst Ratings Changes

CE has been the subject of several research reports. Wells Fargo & Company cut shares of Celanese from an “overweight” rating to an “equal weight” rating and lowered their price objective for the company from $165.00 to $115.00 in a research report on Tuesday, November 5th. Jefferies Financial Group dropped their price objective on shares of Celanese from $102.00 to $82.00 in a research report on Thursday, December 5th. Bank of America upgraded Celanese from an “underperform” rating to a “buy” rating and decreased their price objective for the company from $95.00 to $88.00 in a research report on Tuesday, January 14th. Piper Sandler dropped their target price on Celanese from $98.00 to $77.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Finally, BMO Capital Markets cut Celanese from a “market perform” rating to an “underperform” rating and decreased their price target for the company from $138.00 to $76.00 in a report on Monday, November 11th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, Celanese currently has a consensus rating of “Hold” and an average price target of $102.06.

View Our Latest Analysis on Celanese

Celanese Stock Down 1.2 %

Shares of NYSE:CE opened at $68.06 on Monday. The company has a 50 day moving average price of $69.73 and a two-hundred day moving average price of $101.76. The company has a debt-to-equity ratio of 1.47, a quick ratio of 0.76 and a current ratio of 1.37. The company has a market capitalization of $7.44 billion, a PE ratio of 6.85, a PEG ratio of 1.37 and a beta of 1.17. Celanese Co. has a 52 week low of $64.05 and a 52 week high of $172.16.

About Celanese

(Free Report)

Celanese Corporation, a chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. It operates through Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics.

Recommended Stories

Institutional Ownership by Quarter for Celanese (NYSE:CE)

Receive News & Ratings for Celanese Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celanese and related companies with MarketBeat.com's FREE daily email newsletter.